Psychedelic Drugs Market Forecast to Reach $6.4 Billion by 2034: Psilocybin and Ketamine Therapies Gain Traction, Driving the Market at 12.17% CAGR
24 janv. 2024 14h26 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Psychedelic Drugs Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. With the global...
NIDA Director to Deliver Keynote; Innovative Toxicology Research to Feature at 2024 ACMT Annual Scientific Meeting and Symposia in Washington, DC
17 janv. 2024 11h18 HE
|
American College of Medical Toxicology
Phoenix, AZ, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The American College of Medical Toxicology is pleased to announce the 2024 ACMT Annual Scientific Meeting (ASM) and Symposia taking place April 10 - 14...
ARC Opens Applications for 2024 Substance Use Disorder Recovery-to-Work Projects
08 janv. 2024 14h00 HE
|
Appalachian Regional Commission
Washington, DC, Jan. 08, 2024 (GLOBE NEWSWIRE) -- WASHINGTON, D.C., January 8, 2024—The Appalachian Regional Commission (ARC) issued a Notice of Solicitation of Applications for its Investments...
United States Virtual Mental Health Services Market Report 2023: A $2.88 Billion Industry by 2028 - Industry Size, Share, Trends, Opportunity, and Forecasts
05 janv. 2024 03h38 HE
|
Research and Markets
Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The "United States Virtual Mental Health Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added...
AdCare Hospital Designated as a Blue Distinction® Center for Substance Use Treatment and Recovery
21 déc. 2023 10h15 HE
|
AdCare Hospital
WORCESTER, Mass., Dec. 21, 2023 (GLOBE NEWSWIRE) -- AdCare Hospital, a leading provider of services for co-occurring mental health and substance use disorders, has been recognized by Blue Cross Blue...
Opioid and Stimulant Overdose Reporting Program to Expand Under Increased Federal Funding
17 oct. 2023 12h45 HE
|
American College of Medical Toxicology
Phoenix, AZ, Oct. 17, 2023 (GLOBE NEWSWIRE) -- In September of 2022, the FDA awarded the American College of Medical Toxicology’s (ACMT) Toxicology Investigators Consortium (ToxIC) a 5-year $7.9...
Out-of-Hospital Naloxone Administration to be Studied in New Federally-Funded Project
02 oct. 2023 11h31 HE
|
American College of Medical Toxicology
Phoenix, AZ, Oct. 02, 2023 (GLOBE NEWSWIRE) -- In September 2023, the FDA awarded the American College of Medical Toxicology’s (ACMT) Toxicology Investigators Consortium (ToxIC) through its Broad...
Opioid Use Disorder Market Insights, Epidemiology and Forecasts, 2032: Treatment, Drug Class, Therapies, Outlook, Pipeline Activities, Treatment Programs
29 sept. 2023 10h13 HE
|
Research and Markets
Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Opioid Use Disorder - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The...
ARC Awards Nearly $14 Million to 43 Projects Supporting Appalachians Recovering from Substance Use Disorder
11 sept. 2023 11h30 HE
|
Appalachian Regional Commission
Washington, D.C., Sept. 11, 2023 (GLOBE NEWSWIRE) -- September 11, 2023—Today, the Appalachian Regional Commission (ARC) awarded nearly $14 million to 43 projects through its Investments Supporting...
What Genetics is Telling Us About Substance Use Disorders - A Free Webinar from the Brain & Behavior Research Foundation
29 juin 2023 14h55 HE
|
Brain & Behavior Research Foundation
New York, June 29, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “What Genetics is Telling Us About Substance Use Disorders” on Tuesday,...